BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1417388)

  • 1. The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.
    Gansevoort RT; Apperloo AJ; Heeg JE; de Jong PE; de Zeeuw D
    Arch Intern Med; 1992 Oct; 152(10):2137-9. PubMed ID: 1417388
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of different antihypertensive drugs on human diabetic proteinuria.
    Weidmann P; Boehlen LM; de Courten M
    Nephrol Dial Transplant; 1993; 8(7):582-4. PubMed ID: 8396739
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.
    Gansevoort RT; Sluiter WJ; Hemmelder MH; de Zeeuw D; de Jong PE
    Nephrol Dial Transplant; 1995 Nov; 10(11):1963-74. PubMed ID: 8643149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological prevention and treatment of diabetic nephropathy].
    Aitio ML
    Duodecim; 1993; 109(6):503-11. PubMed ID: 8062718
    [No Abstract]   [Full Text] [Related]  

  • 5. A comprehensive review of antihypertensive agents providing renal protection.
    Kalus JS; White CM
    Conn Med; 2001 Oct; 65(10):587-91. PubMed ID: 11702517
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetic nephropathy: pathogenetic basis for treatment.
    Reasner CA; DeFronzo R
    Contemp Intern Med; 1994 Oct; 6(10):30-2, 35-40. PubMed ID: 10150289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renoprotective effect of Blood pressure control on progression of diabetic retinopathies].
    Katayama S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():389-93. PubMed ID: 15999740
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetic nephropathy.
    Castellino P; Tuttle KR; DeFronzo RA
    Curr Ther Endocrinol Metab; 1994; 5():426-36. PubMed ID: 7704768
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating proteinuria in a diabetic patient despite hyperkalaemia due to hyporeninaemic hypoaldosteronism.
    van Nieuwkoop C; Ijpelaar DH; Bolk JH
    Neth J Med; 2007 Feb; 65(2):75-7. PubMed ID: 17379933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?
    Lewis EJ; Lewis JB
    J Am Soc Nephrol; 2004 May; 15(5):1358-60. PubMed ID: 15100380
    [No Abstract]   [Full Text] [Related]  

  • 11. [Type 2 diabetes and nephropathy--new studies, new treatment strategies?].
    Os I; Stenehjem A; Høieggen A; Draganov B; Jenssen T; Holdaas H
    Tidsskr Nor Laegeforen; 2002 Apr; 122(9):918-20. PubMed ID: 12082835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Considerations on the treatment of incipient diabetic nephropathy (lst of 2 parts)].
    Pérez Blanco FJ; Manzanares L; Moreno G; Cabello MJ
    An Med Interna; 1996 Apr; 13(4):193-7. PubMed ID: 8688481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive therapy in the presence of proteinuria.
    Sarafidis PA; Khosla N; Bakris GL
    Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to the treatment of diabetic nephropathy.
    Burke JM
    Pharm Pract Manag Q; 1997 Jul; 17(2):26-35. PubMed ID: 10168175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel blockers for treatment of diabetic nephropathy.
    Murray KM
    Clin Pharm; 1991 Nov; 10(11):862-5. PubMed ID: 1794222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy.
    Kuriyama S; Tomonari H; Abe A; Imasawa T; Hosoya T
    Nephron; 2000 Dec; 86(4):529-30. PubMed ID: 11124615
    [No Abstract]   [Full Text] [Related]  

  • 18. [Kidney failure, proteinuria, and diabetic nephropathy].
    Collart F
    Rev Med Brux; 2003 Sep; 24(4):A257-62. PubMed ID: 14606290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ACE inhibitors and calcium antagonists alone or combined on progression of diabetic nephropathy.
    Lash JP; Bakris GL
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():56-62. PubMed ID: 8643210
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of diabetic nephropathy].
    Barna I
    Orv Hetil; 2003 Jan; 144(4):165-72. PubMed ID: 12621814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.